Indirect costs of diagnosed diabetes (lost productivity)
Metric EI-04 · Series EI: Economic Impact
Indirect costs of diagnosed diabetes (lost productivity) was $106.3 billion in 2022, according to American Diabetes Association.
This figure is reported as Metric EI-04 in The State of Metabolic Health in America, 2026 Baseline Edition: Annual Policy Report (James M. Knox, DOI: 10.5281/zenodo.22772957).
Definition
This metric measures indirect costs of diagnosed diabetes (lost productivity) among u.s. adults with diagnosed diabetes. The unit of measurement is dollars annually. The geographic scope is United States.
Current Value
| Value | Data Year | Population | Geography |
|---|---|---|---|
| $106.3 billion | 2022 | U.S. adults with diagnosed diabetes | United States |
Source
American Diabetes Association.
Methodological Notes
This figure is drawn from American Diabetes Association. Where a second source reports a different figure for the same condition, both values and the reason for the discrepancy are documented in the report rather than reconciled.
See Methodology and Sources for the full source selection criteria and conflict resolution approach.
Related Metrics
Cite This Metric
Last reviewed: October 2026